top of page

KSL to attend Medlab Middle East at the Dubai World Trade Centre, February 6-9, 2023

KSL Biomedical will be a featured exhibitor at Medlab Middle East on February 6-9, 2023 at the Dubai World Trade Center. In addition to its strategic location in the growing medical market of the region, this annual, international conference showcases technological innovations across all disciplines in the medical laboratory industry.

"We are so excited about the potential for growth in this expanding sector," says KSL CEO Kevin Lawson. "We are poised to bring the same quality and expertise that we already provide to our many partners in our growing service regions worldwide." With a broad base of internationally-managed laboratories and companies, KSL Biomedical provides vertically integrated development and operational resources to not only manufacture biotechnology products, but also obtain regulatory clearance and the commercialization and marketing of biotech properties in product and service models, with a focus on LDT, IVD, and CDx. This comprehensive structure allows KSL to meet its customers exactly where their needs are, and to pivot with changing market conditions and new developments in both regulation and translational medicine.

Visit KSL at Booth Z3 B56 in the US Pavilion this upcoming February 6-9th at the Dubai World Trade Centre to learn more about our full suite of laboratory, regulatory, quality, clinical consulting, and contract research organization services, including:

  • Laboratory test kits (RPR, TPHA, ASO, CRP, RF, Mono, Staph, and Strep) — including novel immunoassays

  • POCT rapid tests

  • Molecular COVID/Flu tests

  • Bactobank

  • Biological/chemical indicators

  • Clinical laboratories

  • Full CRO services

  • Regulatory agent US/International

KSL's laboratory facilities hold FDA and Health Canada establishment licenses, ISO 13485 and 15189 certification, CAP accreditation, CLIA, and comprehensive USA lab licenses.

  • KSL Biomedical is an R&D, manufacturing, and distribution unit based in the USA.

  • KSL Diagnostics clinical laboratories provide testing services for infectious diseases, hematology/oncology, molecular pathology, immunogenetics, dermatology, rheumatology, gastroenterology, and newborn screening and are based in the USA.

  • KSL Pulse Scientific specializes in the manufacturing and distribution of infectious disease diagnostics, microbiology products and controls, biological indicators, serologic and rapid tests based in Canada.

  • KSL CRO offers regulatory and quality consulting services for US and international regulatory approvals, establishment of compliant QMS for companies in the medical device, IVD, clinical laboratory and pharma space with clinical laboratories capable of executing a broad range of clinical studies.

  • KSL China is a regulatory, quality, and manufacturing support unit and a clinical laboratory unit based in China.


bottom of page